Novo exercises its option for an equity stake in SYNLAB

Munich, 15 December 2016 – SYNLAB Limited (‘SYNLAB’ or ‘the Group’) today announces that Novo A/S (‘Novo’) has exercised its option to acquire an equity stake in the Group. Following the closing of the transaction which is scheduled to take place on 15 December 2016, Novo will own a stake of more than 10% of the equity of SYNLAB Limited.

With the exercise of its option, Novo emphasises its ongoing commitment to facilitate SYNLAB’s expansion and development through significant financial backing for the Group.